Neuroprotective effect of Compound Anisodine in a mouse model with chronic ocular hypertension

• 作 者: Wen-dongLiu;Li-binJiang;
• 机 构: Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Ophthalmol
• 出 处: 第八届亚洲神经眼科大会暨第四届全国神经眼科学术会议
• 发表日期: 2015年期

　　Objective: Compound Anisodine (CA) is a compound preparation made from hydrobromide anisodine and procaine hydrochloride.The former is an M-choline receptor blocker with the function of regulating the vegetative nervous system, improving microcirculation, and so on.The latter is an antioxidant with the activities of neuroprotection.This study aims to investigate the potential neuroprotection of CA, which affects the degeneration of the retinal ganglion cells (RGCs) in an animal model with chronic ocular hypertension.